Key result
First Gaza polio case in 25 years highlights silent cVDPV2 spread requiring urgent nOPV2 vaccination.
Why the study?
The silent spread of circulating vaccine-derived poliovirus type 2 in Gaza has become a major public health emergency exacerbated by ongoing conflict, inadequate sanitation, and limited healthcare access.
Answers are grounded in this paper and cite their sources.
The review highlights the urgent public health emergency of cVDPV2 spread in Gaza and the need for humanitarian access and vaccination campaigns to contain the outbreak.
The silent spread of circulating vaccine-derived poliovirus type 2 (cVDPV2) in Gaza has become a major public health emergency, exacerbated by ongoing conflict, inadequate sanitation, and limited healthcare access. The virus was discovered in sewage samples from Khan Younis and Deir al Balah, and genetic analysis linked it to a strain found in Egypt in late 2023. The first polio case in Gaza in 25 years was confirmed in August 2024 in a 10-month-old child. This review explores the epidemiology of cVDPV2 in Gaza, its relationship to regional strains, and the risk factors that exacerbate transmission. It describes the role of various polio vaccines, including the novel oral polio vaccine type 2 (nOPV2), in emergency campaigns coordinated by WHO, UNICEF, and the Palestinian Ministry of Health. The review further explores into Gaza’s unique “Gaza system” of combined vaccination, the challenges of maintaining cold-chain logistics, and the significance of wastewater surveillance. To contain the outbreak and prevent poliomyelitis from resurging in vulnerable populations, humanitarian access, ceasefire enforcement, and global cooperation are urgently needed.
No takes yet. Share an insight, caveat, or question.
Shaikh et al. (2025) conducted a review in circulating vaccine-derived poliovirus type 2 (cVDPV2). novel oral polio vaccine type 2 (nOPV2) was evaluated. The first polio case in Gaza in 25 years was confirmed in a 10-month-old child, highlighting the silent spread of cVDPV2 and the urgent need for emergency vaccination campaigns using nOPV2.
Synapse has enriched 10 related papers. Consider them for comparative context: